View More Recent Stories

Jan 4, 2022 07:30AM Dusquetide Demonstrates Positive Anti-tumor Efficacy in Multiple Nonclinical Animal Studies
Dec 2, 2021 07:34AM Soligenix, Inc. (SNGX) Reports Successful Protection from Sudan Ebolavirus with a Bivalent Thermostabilized Filovirus Vaccine
Dec 2, 2021 07:30AM Soligenix Announces Successful Protection using a Bivalent Thermostabilized Filovirus Vaccine
Nov 12, 2021 07:30AM Soligenix Announces Recent Accomplishments And Third Quarter 2021 Financial Results
Nov 8, 2021 07:30AM Soligenix, Inc. (SNGX) Granted UK Pediatric Investigational Plan Waiver for HyBryte in CTCL
Nov 8, 2021 07:30AM Soligenix Granted Pediatric Investigational Plan Waiver for HyBryte™ in CTCL in the United Kingdom
Nov 4, 2021 07:55AM Soligenix, Inc. (SNGX) Announces Publication Demonstrating Enduring Protection of its Thermostable RiVax Vaccine
Nov 4, 2021 07:30AM Soligenix Announces Publication Demonstrating Enduring Protection of its Thermostable RiVax® Vaccine
Nov 1, 2021 07:30AM Thermostable Vaccine Technology Platform to be Presented at the 6th International Conference on Vaccines Research and Development
Oct 12, 2021 07:30AM HyBryte™ FLASH Study Selected as a 'Top Poster' Winner for Presentation at the National Organization for Rare Disorders' Rare Diseases and Orphan Products Breakthrough Summit
Sep 28, 2021 07:39AM Soligenix (SNGX) Announces Accelerated Publication Demonstrating Efficacy and Broad Neutralizing Activity of its COVID-19 Vaccine in Non-Human Primates
Sep 28, 2021 07:30AM Soligenix Announces Accelerated Publication Demonstrating Efficacy and Broad Neutralizing Activity of its COVID-19 Vaccine in Non-Human Primates
Sep 27, 2021 07:30AM Soligenix Invited to Present at the Cantor Fitzgerald Global Healthcare Conference
Sep 16, 2021 08:24AM Soligenix, Inc. (SNGX) to Advance Synthetic Hypericin Development in Psoriasis
Sep 16, 2021 08:22AM Soligenix to Advance Synthetic Hypericin Development in Psoriasis
Sep 9, 2021 07:32AM Soligenix, Inc. (SNGX) Active Ingredient Hypericin Granted FDA Orphan Drug Designation for Treatment of T-cell Lymphoma
Sep 9, 2021 07:30AM FDA Grants Soligenix Orphan Drug Designation for the Treatment of T-cell Lymphoma
Aug 23, 2021 07:30AM Soligenix Announces Publication Demonstrating Successful Formulation and Heat Stabilization of Filovirus Vaccine Platform for Ebola and Marburg Virus Diseases
Aug 18, 2021 08:53AM Soligenix (SNGX) Announces Positive Preclinical Data with Multiple Heat Stable Filovirus Vaccine Candidates
Aug 18, 2021 08:52AM Soligenix Announces Positive Preclinical Data with Multiple Heat Stable Filovirus Vaccine Candidates
Aug 13, 2021 07:30AM Soligenix Announces Recent Accomplishments And Second Quarter 2021 Financial Results
Jun 22, 2021 07:30AM HyBryte™ Positive Pivotal Phase 3 FLASH Study Selected for Presentation at the United States Cutaneous Lymphoma Consortium (USCLC) Annual Meeting
Aug 30, 2017 10:00AM Soligenix, Inc. (Nasdaq: SNGX) to Ring The Nasdaq Stock Market Closing Bell
Jun 21, 2016 09:00AM Vista Partners Publishes June 2016 Macroeconomic & Investment Newsletter
Apr 19, 2016 09:30AM Vista Partners Updates Coverage on Soligenix, Inc. (Ticker: SNGX)
Jan 6, 2016 09:00AM Vista Partners Publishes January 2016 Newsletter
Dec 18, 2015 09:00AM Vista Partners Updates Coverage on Soligenix, Inc. (Ticker: SNGX); Price Target $7.00
Dec 10, 2015 01:20PM What $40 or Less Oil Means to the Economy
Nov 10, 2015 09:00AM What Summer Downturn?
Sep 24, 2015 09:00AM Vista Partners Updates Coverage on Soligenix, Inc. (Ticker: SNGX); Price Target $7.00
Sep 15, 2015 12:20PM Should We Believe the Fed Will Not Raise Rates in 2015?
Jul 7, 2015 09:00AM Vista Partners Publishes July 2015 Macroeconomic & Investment Newsletter
Jun 23, 2015 07:15AM Soligenix Announces Collaboration with the National Organization for Rare Disorders and the Cutaneous Lymphoma Foundation in Advancing its Phase 3 Study of SGX301 for the Treatment of Cutaneous T-Cell
May 21, 2015 09:00AM Vista Partners Updates Coverage on Soligenix, Inc. (Ticker: SNGX); Price Target $7.00
May 13, 2015 09:00AM Vista Partners Publishes May 2015 Macroeconomic & Investment Newsletter
Apr 8, 2015 08:00AM Vista Partners Publishes April 2015 Macroeconomic & Investment Newsletter
Mar 6, 2015 11:15AM Vista Partners Publishes March 2015 Macroeconomic & Investment Newsletter
View More Recent Stories